Plain-English translation of NCT06280079 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether an ultra-high-caloric, fatty nutritional supplement can help people with ALS live longer and slow down the disease's progression. ALS patients often lose weight rapidly and have faster metabolisms, which worsens their condition. Based on earlier research, this supplement—taken as a daily drink in addition to normal food—may help people maintain their weight and strength.
People with ALS lose weight very quickly because their bodies burn calories much faster than normal, and this weight loss makes the disease progress faster. Earlier studies suggested that high-calorie, fatty nutrition might help slow this decline, but the results weren't strong enough across all patients. This new trial uses a higher dose of the same treatment and focuses on patients most likely to benefit.
You would be randomly assigned to drink either the high-calorie fatty supplement or a placebo (a non-active drink) four times per day, in addition to eating normally. The study tracks your weight, muscle strength, and disease progression over time through regular clinical visits and blood tests that measure certain markers related to ALS. The goal is to see whether the supplement helps you maintain your weight and slow your functional decline.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Germany